{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:48:57Z","timestamp":1789145337106,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agenzia Italiana del Farmaco, Ministero della Salute,Italy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11136-026-04193-0","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T13:10:04Z","timestamp":1772370604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-world evaluation of health-related quality of life in hematology patients treated with rituximab: results of a multicentric cross-sectional cohort study"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-1290","authenticated-orcid":false,"given":"Silvana A. M.","family":"Urru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Spila Alegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Paoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Guella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Murru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Bucaneve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Formoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Fozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Fulgenzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Musicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Campomori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SURE Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,1]]},"reference":[{"issue":"8","key":"4193_CR1","first-page":"1245","volume":"24","author":"JM Giesinger","year":"2021","unstructured":"Giesinger, J. M., Efficace, F., Aaronson, N. K., Calvert, M., Kyte, D., Cottone, F., et al. (2021). Past and current practice of patient-reported outcome measurement in randomized cancer clinical trials: A systematic review. Value in Health : The Journal of the international Society for Pharmacoeconomics and Outcomes Research, 24(8), 1245\u20131252.","journal-title":"Value in Health : The Journal of the international Society for Pharmacoeconomics and Outcomes Research"},{"issue":"3","key":"4193_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s11136-013-0534-2","volume":"23","author":"AB Smith","year":"2014","unstructured":"Smith, A. B., Cocks, K., Parry, D., & Taylor, M. (2014). Reporting of health-related quality of life (HRQOL) data in oncology trials: A comparison of the European organization for research and treatment of cancer quality of life (EORTC QLQ-C30) and the functional assessment of cancer Therapy-General (FACT-G). Quality of Life Research, 23(3), 971\u2013976.","journal-title":"Quality of Life Research"},{"issue":"12","key":"4193_CR3","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.3390\/ijms22126321","volume":"22","author":"P Karagianni","year":"2021","unstructured":"Karagianni, P., Giannouli, S., & Voulgarelis, M. (2021). From the (Epi)genome to metabolism and vice versa; examples from hematologic malignancy. International Journal of Molecular Sciences, 22(12), 6321. https:\/\/doi.org\/10.3390\/ijms22126321","journal-title":"International Journal of Molecular Sciences"},{"key":"4193_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.blre.2018.07.003","volume":"33","author":"M Damlaj","year":"2019","unstructured":"Damlaj, M., El Fakih, R., & Hashmi, S. K. (2019). Evolution of survivorship in lymphoma, myeloma and leukemia: Metamorphosis of the field into long-term follow-up care. Blood Reviews, 33, 63\u201373. https:\/\/doi.org\/10.1016\/j.blre.2018.07.003PMID:30093158.","journal-title":"Blood Reviews"},{"issue":"6","key":"4193_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.sapharm.2024.03.005","volume":"20","author":"S Shrestha","year":"2024","unstructured":"Shrestha, S., Iqbal, A., Teoh, S. L., Khanal, S., Gan, S. H., Lee, S. W. H., et al. (2024). Impact of pharmacist-delivered interventions on pain-related outcomes: An umbrella review of systematic reviews And meta-analyses. Res Social Adm Pharm, 20(6), 34\u201351. https:\/\/doi.org\/10.1016\/j.sapharm.2024.03.005PMID:38514293.","journal-title":"Res Social Adm Pharm"},{"key":"4193_CR6","doi-asserted-by":"publisher","first-page":"502431","DOI":"10.1155\/2015\/502431","volume":"2015","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Wu, H., & Xu, F. (2015). Impact of clinical pharmacy services on KAP and QOL in cancer patients: A single-center experience. Biomed Research International, 2015, 502431. https:\/\/doi.org\/10.1155\/2015\/502431PMID:26697487; PMCID:PMC4677164.","journal-title":"Biomed Research International"},{"issue":"20","key":"4193_CR7","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. (2013). World medical association declaration of helsinki: Ethical principles for medical research involving human subjects. Journal of the American Medical Association, 310(20), 2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"4193_CR8","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1038\/s41598-021-85563-1","volume":"11","author":"SAM Urru","year":"2021","unstructured":"Urru, S. A. M., Spila Alegiani, S., Guella, A., Traversa, G., & Campomori, A. (2021). Safety of switching between rituximab biosimilars in onco-hematology. Scientific Reports, 11(1), 5956. https:\/\/doi.org\/10.1038\/s41598-021-85563-1PMID:33727667; PMCID:PMC7966361.","journal-title":"Scientific Reports"},{"issue":"10020","key":"4193_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/S0140-6736(15)00667-4","volume":"387","author":"M Dreyling","year":"2016","unstructured":"Dreyling, M., Jurczak, W., Jerkeman, M., et al. (2016). Ibrutinib versus Temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: An international, randomised, open-label, phase 3 study. Lancet, 387(10020), 770\u2013778.","journal-title":"Lancet"},{"issue":"12","key":"4193_CR10","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1080\/10428194.2017.1326034","volume":"58","author":"G Hess","year":"2017","unstructured":"Hess, G., Rule, S., Jurczak, W., et al. (2017). Health-related quality of life data from a phase III, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus Temsirolimus. Leukaemia & Lymphoma, 58(12), 2824\u20132832.","journal-title":"Leukaemia & Lymphoma"},{"issue":"4","key":"4193_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1182\/bloodadvances.2019001026","volume":"4","author":"RT Maziarz","year":"2020","unstructured":"Maziarz, R. T., Waller, E. K., Jaeger, U., et al. (2020). Patient-reported long-term quality of life after tisagenlecleucel in relapsed\/refractory diffuse large B-cell lymphoma. Blood Adv, 4(4), 629\u2013637.","journal-title":"Blood Adv"},{"issue":"11","key":"4193_CR12","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1182\/blood.V106.11.750.750","volume":"106","author":"D Cella","year":"2005","unstructured":"Cella, D., Webster, K., Cashy, J., et al. (2005). Development of a measure of health-related quality of life for non-Hodgkin\u2019s lymphoma clinical research: The functional assessment of cancer Therapy\u2013lymphoma (FACT-Lym). Blood, 106(11), 750.","journal-title":"Blood"},{"key":"4193_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/147176","volume":"1","author":"FJ Hlubocky","year":"2013","unstructured":"Hlubocky, F. J., Webster, K., Cashy, J., Beaumont, J., & Cella, D. (2013). The development and validation of a measure of health-related quality of life for non-Hodgkin\u2019s lymphoma: The functional assessment of cancer Therapy\u2013lymphoma (FACT-Lym). Lymphoma, 1, 1\u20139.","journal-title":"Lymphoma"},{"issue":"3","key":"4193_CR14","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1078155220976801","volume":"27","author":"CS Oliveira","year":"2021","unstructured":"Oliveira, C. S., Silva, M. P., Miranda, \u00cd. K. S. P. B., Calumby, R. T., & de Ara\u00fajo-Calumby, R. F. (2021). Impact of clinical pharmacy in oncology and hematology centers: A systematic review. Journal of Oncology Pharmacy Practice : official Publication of the International Society of Oncology Pharmacy Practitioners, 27(3), 679\u2013692.","journal-title":"Journal of Oncology Pharmacy Practice : official Publication of the International Society of Oncology Pharmacy Practitioners"},{"issue":"9307","key":"4193_CR15","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/S0140-6736(02)07810-8","volume":"359","author":"L Fallowfield","year":"2002","unstructured":"Fallowfield, L., Jenkins, V., Farewell, V., Saul, J., Duffy, A., & Eves, R. (2002). Efficacy of A cancer research UK communication skills training model for oncologists: A randomised controlled trial. Lancet, 359(9307), 650\u2013656. https:\/\/doi.org\/10.1016\/S0140-6736(02)07810-8","journal-title":"Lancet"},{"issue":"1","key":"4193_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/pon.1710","volume":"20","author":"A Molassiotis","year":"2011","unstructured":"Molassiotis, A., Wilson, B., Blair, S., Howe, T., & Cavet, J. (2011). Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psychooncology, 20(1), 88\u201397. https:\/\/doi.org\/10.1002\/pon.1710PMID:20187072.","journal-title":"Psychooncology"},{"issue":"12","key":"4193_CR17","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1007\/s11136-020-02602-6","volume":"29","author":"B Senf","year":"2020","unstructured":"Senf, B., Grabowski, K., Spielmann, N., & Fettel, J. (2020). Quality of life and distress assessed with self and external assessment screening tools in patients with hematologic malignancies attending treatment in an acute hospital. Quality of Life Research, 29(12), 3375\u20133385. https:\/\/doi.org\/10.1007\/s11136-020-02602-6","journal-title":"Quality of Life Research"},{"key":"4193_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13012-018-0784-z","volume":"13","author":"Y Bombard","year":"2018","unstructured":"Bombard, Y., Baker, G. R., Orlando, E., et al. (2018). Engaging patients to improve quality of care: A systematic review. Implement Sci, 13, 98. https:\/\/doi.org\/10.1186\/s13012-018-0784-z","journal-title":"Implement Sci"},{"key":"4193_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon, N., Shakib, S., Kalisch-Ellett, L., et al. (2017). What is polypharmacy? A systematic review of definitions. Bmc Geriatrics, 17, 230.","journal-title":"Bmc Geriatrics"},{"issue":"2","key":"4193_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","volume":"21","author":"LE Davies","year":"2020","unstructured":"Davies, L. E., Spiers, G., Kingston, A., et al. (2020). Adverse outcomes of polypharmacy in older people: Systematic review of reviews. Journal of the American Medical Directors Association, 21(2), 181\u2013187.","journal-title":"Journal of the American Medical Directors Association"},{"issue":"4","key":"4193_CR21","first-page":"337","volume":"66","author":"D Sarfati","year":"2016","unstructured":"Sarfati, D., Koczwara, B., & Jackson, C. (2016). The impact of comorbidity on cancer and its treatment. C Ca: A Cancer Journal for Clinicians, 66(4), 337\u2013350.","journal-title":"C Ca: A Cancer Journal for Clinicians"},{"issue":"4","key":"4193_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/jgs.14682","volume":"65","author":"BC Wimmer","year":"2017","unstructured":"Wimmer, B. C., Cross, A. J., Jokanovic, N., et al. (2017). Clinical outcomes associated with medication regimen complexity in older people: A systematic review. Journal of the American Geriatrics Society, 65(4), 747\u2013753.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"4","key":"4193_CR23","first-page":"685","volume":"34","author":"JD Haag","year":"2021","unstructured":"Haag, J. D., Yost, K. J., Kosloski Tarpenning, K. A., et al. (2021). Effect of an integrated clinical pharmacist on the drivers of provider burnout in the primary care setting. Journal of the American Board of Family Medicine : Jabfm, 34(4), 685\u2013693.","journal-title":"Journal of the American Board of Family Medicine : Jabfm"},{"issue":"2","key":"4193_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/jcpt.12242","volume":"40","author":"N Vantard","year":"2015","unstructured":"Vantard, N., Ranchon, F., Schwiertz, V., et al. (2015). EPICC study: Evaluation of pharmaceutical intervention in cancer care. Journal of Clinical Pharmacy and Therapeutics, 40(2), 196\u2013203.","journal-title":"Journal of Clinical Pharmacy and Therapeutics"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04193-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:59:11Z","timestamp":1778680751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04193-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,1]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4193"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04193-0","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,1]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}